Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Roberto Augusto Caffaro MD, PhD"'
Autor:
Isabela Rodrigues Tavares MD, Roberto Augusto Caffaro MD, PhD, Maria Fernanda Portugal MD, PhD, Camilla Moreira Ribeiro PhD, Viviane Santana da Silva MD, Emily Krupa MD, Srdjan Nikolovski MD, Karen Falcão de Britto MD, Ana Cláudia Gomes Pereira Petisco MD, Maria Cristina Miranda MD, Sandra Gomes de Souza Santos MD, Marcela da Silva Dourado MD, Paula Veloso Siqueira PhD, Fakiha Siddiqui PhD, Jawed Fareed PhD, Eduardo Ramacciotti MD, PhD
Publikováno v:
Clinical and Applied Thrombosis/Hemostasis, Vol 30 (2024)
Venous thromboembolism (VTE), including deep venous thrombosis (DVT) and pulmonary embolism (PE), represents a substantial healthcare challenge. Provoked and unprovoked DVT cases carry distinct risks and treatment considerations. Recognizing the limi
Externí odkaz:
https://doaj.org/article/e4e12f55ac934fa3bb9edb99f649170a
Autor:
Eduardo Ramacciotti MD, PhD, Leandro Barile Agati PhD, Giuliano Giova Volpiani MD, Karen Falcão Brito MD, Camilla Moreira Ribeiro PhD, Valéria Cristina Resende Aguiar MD, Lorenzo Storino Ramacciotti, Alexia Paganotti, Felipe Menegueti Pereira, Roberto Augusto Caffaro MD, PhD, Alexandre Fioranelli MD, PhD, Rogério Krakauer MD, Heron Rhydan Saad Rached, Nelson Wolosker MD, PhD, Sonia S. Anand MD, John W. Eikelboom MBBS, Renato Delascio Lopes MD, PhD
Publikováno v:
Clinical and Applied Thrombosis/Hemostasis, Vol 28 (2022)
Background The COMPASS trial demonstrated that in patients with peripheral arterial disease, the combination of rivaroxaban and aspirin compared with aspirin reduces the risk of major adverse limb events, but it is not known whether this combination
Externí odkaz:
https://doaj.org/article/5a29b0514e6c4f09880b84a9f73782d8
Autor:
Dalia Qneibi MD, Eduardo Ramacciotti MD, PhD, Ariane Scarlatelli Macedo MD, Roberto Augusto Caffaro MD, PhD, Leandro Barile Agati PhD, Fakiha Siddiqui BDS, Ahmed Kouta MS, Debra Hoppensteadt PhD, Jawed Fareed PhD, Charles A. Carter PharmD, MBA, BS
Publikováno v:
Clinical and Applied Thrombosis/Hemostasis, Vol 26 (2020)
Low molecular weight heparins (LMWH) represent depolymerized heparin prepared by various methods that exhibit differential, biochemical and pharmacological profiles. Enoxaparin is prepared by benzylation followed by alkaline depolymerization of porci
Externí odkaz:
https://doaj.org/article/2eb76c0d48ba41a1826ac70efa25cd51
Autor:
Eduardo Ramacciotti MD, PhD, Leandro B. Agati PhD, Roberto Augusto Caffaro MD, PhD, Giuliano G. Volpiani MD, Renato D. Lopes MD, PhD, Anthony J. Comerota MD, Jawed Fareed PhD
Publikováno v:
Clinical and Applied Thrombosis/Hemostasis, Vol 25 (2019)
Direct oral anticoagulants (DOACs) are now widely used for the management of venous thromboembolism (VTE) that now includes cancer-associated thrombosis. This review summarizes recent data on VTE prophylaxis and treatment, new challenges, guidelines,
Externí odkaz:
https://doaj.org/article/31886d6b21ec4630961d797b7c05ea41